Global Poultry Vaccines Market Growth (Status and Outlook) 2025-2031
The global Poultry Vaccines market size is predicted to grow from US$ 4543 million in 2025 to US$ 5974 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
Vaccination plays an important part in the health management of the poultry flock. There are numerous diseases that are prevented by vaccinating the birds against them. A vaccine helps to prevent a particular disease by triggering or boosting the bird’s immune system to produce antibodies that in turn fight the invading causal organisms.
Global key poultry vaccines players hold a share about Merck, Boehringer Ingelheim and Ceva etc. The top 3 companies hold a share about 35%. Asia-Pacific is the largest market with a share about 51%, followed by North America and Europe.
In terms of product, killed vaccine is the largest segment with a share about 72%. And in terms of applications, the largest application is NDV with a share about 25%.
LPI (LP Information)' newest research report, the “Poultry Vaccines Industry Forecast” looks at past sales and reviews total world Poultry Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Poultry Vaccines sales for 2025 through 2031. With Poultry Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poultry Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Poultry Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Poultry Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Poultry Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poultry Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poultry Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Poultry Vaccines market by product type, application, key players and key regions and countries.
Segmentation by Type:
Live
Attenuated
Killed
Segmentation by Application:
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Boehringer Ingelheim
Ceva
Zoetis
Vaxxinova®
Elanco
QYH Biotech Co., Ltd
Pulike
Phibro Animal Health Corporation
JinYu Biotechnology
Harbin Pharmaceutical Group
MEVAC
Venky's
Japfa Comfeed Indonesia
Nisseiken
Hile
Hester Biosciences
Please note: The report will take approximately 2 business days to prepare and deliver.